Provided by Tiger Fintech (Singapore) Pte. Ltd.

Spero Therapeutics Inc.

0.7542
+0.01421.92%
Post-market: 0.75420.00000.00%17:33 EDT
Volume:35.94K
Turnover:27.62K
Market Cap:42.16M
PE:-0.59
High:0.7860
Open:0.7400
Low:0.7400
Close:0.7400
Loading ...
Feb 10, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 05, 2021

Major Issues Report

8-K - Current report
Feb 02, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 02, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 19, 2021

Major Issues Report

8-K - Current report
Dec 17, 2020

Major Issues Report

8-K - Current report
Dec 07, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Dec 03, 2020

Major Issues Report

8-K - Current report
Nov 05, 2020

Major Issues Report

8-K - Current report
Nov 05, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 28, 2020

Major Issues Report

8-K - Current report
Sep 23, 2020

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Sep 16, 2020

Major Issues Report

8-K - Current report
Sep 14, 2020

Major Issues Report

8-K - Current report
Sep 09, 2020

Major Issues Report

8-K - Current report
Sep 08, 2020

Major Issues Report

8-K - Current report
Aug 06, 2020

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Aug 06, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 06, 2020

Major Issues Report

8-K - Current report
Jun 04, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership